MedTrace Logo

Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.

NCT02405754 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 667

Last updated 2019-01-31

No results posted yet for this study

Summary

This is a retrospective study, designed to be conducted at a single-center in the US. The study will conduct a one-time data abstraction from approximately 500 patient medical charts who received Age/Sex/Gene Expression score (ASGES) also knows as Corus CAD testing, by order of the Principal Investigator. Limited demographic data and patient data pertaining to cardiology referral or advanced diagnostic testing will be collected. All data will be collected anonymously.

Conditions

Interventions

DIAGNOSTIC_TEST

Corus CAD (ASGES)

Age/Sex/Gene Expression Score - ASGES

Sponsors & Collaborators

  • CardioDx

    lead INDUSTRY

Principal Investigators

  • Linda Ross, MPH · CardioDx, Inc.

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-04-30
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02405754 on ClinicalTrials.gov